Advertisement
AXDX 외환 뉴스
Accelerate Diagnostics Q2 Net Loss Narrows
Vitro diagnostics company Accelerate Diagnostics, Inc. (AXDX) announced Monday that net loss for the second quarter narrowed to $17.80 million or $0.23 per share from $21.67 million or $0.36 per share in the prior-year quarter.
RTTNews
|
1113 일 전
